Myectomy Improves Long-Term Survival and Quality of Life in Children With Obstructive Hypertrophic Cardiomyopathy

For children with obstructive hypertrophic cardiomyopathy (HCM), doctors now view septal myectomy not just as a last resort, but as a way to change a child’s life. New clinical reports show that surgically removing the extra thickened heart muscle can dramatically improve long-term survival and give children a much better quality of life than medicines alone. It often lets a child breathe more easily, run with friends and do things they were forced to abandon. This matters because choices made in childhood affect not just a child’s immediate health but also their schooling, activities and family life for years to come.

Why It Matters

While some kids will have a milder form of the disease that responds to treatment and changes in lifestyle, others will suffer from a severe blockage of the flow of the blood (left ventricular outflow tract obstruction), which causes breathlessness, chest pains, or even fainting during physical activities. The kid with the severe form of the obstruction will need breaks while playing or working on his/her homework due to dizziness. All these complications will negatively affect their development and prevent them from taking part in sports activities. It should be noted that this disease is quite prevalent (1 person in 500 suffers from it) and is one of the most common reasons for the sudden cardiac death of a young individual.

Medication may provide symptomatic relief (beta-blockers slow down the heartbeat and alleviate chest pain), but medicines cannot solve the problem of muscle blockage. They provide relief, but the additional muscle tissue continues to prevent blood from exiting the heart. Open heart surgery called septal myectomy involves removal of the obstructing muscle tissue to restore blood flow. Myectomy may have dramatic effects; many children operated on feel much better and resume their usual physical activity. In particular, there are data suggesting that children undergoing myectomy lead lives much longer and healthier than other children treated with medication only. Indeed, some long-term investigations reveal 10-year survival rate of 90% with surgery in comparison to low rates of survival without surgery in earlier studies. Specialists working with these patients say that stamina and tolerance to exercise tend to improve with myectomy, and children often cut or stop using medications they were taking before.

Obviously, however, surgery is not a cure all solution. There are initial risks associated with it that include bleeding, infection, or rhythm disturbances, as well as greater likelihood of complications such as valve damage when performed by an incompetent surgeon. However, in specialized children’s cardiac centers, the risk of such complications is minimal (early mortality is less than 1% in most cases). The procedure demands an extremely competent staff and cardiopulmonary bypass machine, while requiring to stay in hospital for at least a week. Children’s age, body build and unique anatomy of heart influence the difficulty level of the surgery. For instance, small hearts and blood vessels make surgery particularly tricky for infants. Of importance is geographical location as well; a distant specialized center creates additional difficulties with transportation.

Who It Affects

Children with severe HCM and their families are directly impacted by this choice. For a child who tires out during gym class or gets dizzy running around the yard, choosing between strong medicines and surgery can feel urgent. Parents must balance the short-term stress of an operation and recovery against the hope of many years of healthier living. Teenagers may be anxious about whether they can ever play sports, get a driver’s license, or go to college without health restrictions. The decision can feel existential for families, because it may shape the child’s entire future. Genetic counselors often get involved, since HCM usually runs in families and relatives may need screening too.

Pediatric cardiologists and heart surgeons are part of the picture too. A cardiologist needs to recognize when medicines are not enough and know when to refer a child for surgical evaluation. Not every hospital has the expertise – operating on a growing heart is very different than on an adult heart. Evidence shows pediatric myectomy is safest at high-volume centers where teams handle dozens of these cases per year, leading to far better results. Those centers often combine surgery with advanced imaging (like 3D echocardiograms) and have pediatric anesthesiologists and ICU teams. That means many children with HCM might need to travel to a major heart center for the best care.

Hospitals, insurers, and policymakers also have a stake. Concentrating complex surgeries in a few expert centers improves outcomes, but it raises questions of access and cost. Families might need help covering travel, lodging, and time off, which can be expensive. Insurance companies and health systems need to decide how much to support these referrals. However, paying for one effective surgery now could prevent multiple emergency room visits or ICU stays later, and might even avert a heart transplant down the line. Since HCM often runs in families, public health programs and genetics services may also get involved in screening and counseling, which requires coordination and funding.

What Changes

• Choosing myectomy involves both medical facts and personal values. From a medical point of view, the surgery fixes the mechanical problem that no medicine can remove. For a family, it can mean a real chance at a near-normal childhood—playing, going to school, and growing up with fewer limits. But it is still major surgery. The child will go on a heart-lung machine, spend several days in intensive care, and then recover at home for weeks. Some children may need a pacemaker or another procedure later if their heart rhythm or valves need attention. Families need clear, balanced information about both the benefits and the risks. Meanwhile, there are reasons to be hopeful. Surgical techniques and imaging have advanced, allowing very precise planning and safer operations. Research is exploring less invasive ways to relieve obstruction. Multidisciplinary teams (including cardiologists, surgeons, anesthesiologists, geneticists, nurses, and social workers) can tailor care to each child and family. But today, the evidence shows that for the right child, myectomy is the most effective way to improve long-term survival and quality of life. Finally, think system-wide. If experts accept that myectomy boosts survival and well-being in children with obstructive HCM, then healthcare systems should make it easier to do. That means funding more training for pediatric heart teams, building referral and transport networks, and updating care guidelines so every eligible child is evaluated. Insurance plans should cover comprehensive care, and hospitals should coordinate outreach and telehealth to underserved areas. The goal is to ensure a child’s future is shaped by their medical needs, not by their location or insurance coverage. References Cappellaro AP, de Almeida LFC, Gismondi RAOC, Ayala R, Thet MS, Dearani JA. Septal myectomy in pediatric obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis. Pediatric Cardiology. 2025. https://pubmed.ncbi.nlm.nih.gov/41247546/ Griffeth EM, Dearani JA, Schaff HV, et al. Septal myectomy outcomes in children and adolescents with obstructive hypertrophic cardiomyopathy. The Annals of Thoracic Surgery. 2023;116(3):499–507. https://pubmed.ncbi.nlm.nih.gov/37116851/ Ommen SR, Ho CY, Asif IM, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23):e1239–e1311. https://pubmed.ncbi.nlm.nih.gov/38727647/ Arghami A, Dearani JA, Said SM, O’Leary PW, Schaff HV. Hypertrophic cardiomyopathy in children. Annals of Cardiothoracic Surgery. 2017;6(4):376–385. https://pmc.ncbi.nlm.nih.gov/articles/PMC5602192/
• Refer early to a heart center. Children who have symptoms and severe obstruction should not wait for surgery referral. Early consultation at a specialized center will help you find out whether myectomy may be effective. This implies that the idea of surgery is considered not only as an ultimate way if drugs do not work, but as an important step if a child’s life is restricted because of HCM.
• Centralize care in high-volume centers. This operation is very unique. The chances of success for this procedure are very high if this is done by doctors who do this procedure regularly. There should be referral systems that link these patients to centers where they can receive the treatment. Insurances and charities should help out with travel and accommodation costs.
• Plan lifelong follow-up. The septal myectomy procedure helps to relieve the obstruction, but it is not a cure for the condition. It means that the patients require heart examinations throughout their lifetime. Regular evaluation of the patient should involve checking for any abnormalities related to arrhythmias or valve problems, and in some instances, placing of medical devices such as pacemakers or defibrillators. Moreover, the follow-up should also comprise genetic analysis because HCM is mostly a genetically related condition.
• Talk about everyday life, not just survival. When clinicians counsel families, they should explain not only survival statistics but also practical benefits. After a successful myectomy, many children can run, play, and attend school like their peers—things they might not have been able to do on medicine alone. Parents deserve an honest picture: if surgery goes well, a child might join gym class without fainting and live without the constant limits of the heart condition. Of course, they should also understand the surgical risks and the possibility that the child might need further interventions later.
• Improve access and support. Address practical barriers. Pediatric surgeons who specialize in myectomy are rare, so not every hospital can offer the surgery. Hospitals, nonprofits, and governments should create programs to help families—assisting with travel, lodging, and remote consultations with specialists. Expanding telemedicine follow-ups can keep care local when possible. Training programs should ensure more surgeons and heart teams become skilled in pediatric myectomy and congenital heart care.
• Align healthcare policies to long-term outcomes. Rather than concentrate on what helps keep people alive for decades, systems should incentivize preventive and timely care and not only expedited care. Therefore, insurers should cover complete services, ranging from genetic counseling and advanced cardiac imaging prior to surgery, to rehabilitation and psychological assistance after surgery. As an expert procedure performed now may ensure that this person is in better shape when he or she becomes an adult, so should financing of the healthcare system. It is important that insurers recognize that an investment in the heart of a child today will result in a healthier adult tomorrow.